Novo Nordisk A/SNVONYSE
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-33.6%
5Y CAGR-13.9%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-33.6%/yr
vs +15.7%/yr prior
5Y CAGR
-13.9%/yr
Recent deceleration
Acceleration
-49.3pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.45 | -61.6% |
| 2024 | 19.38 | -34.0% |
| 2023 | 29.37 | +15.4% |
| 2022 | 25.45 | +6.6% |
| 2021 | 23.87 | +51.8% |
| 2020 | 15.72 | -1.4% |
| 2019 | 15.94 | +12.2% |
| 2018 | 14.20 | -14.3% |
| 2017 | 16.58 | +16.5% |
| 2016 | 14.23 | - |